1
|
Langhe R, Kelly T. Unanticipated Uterine Torsion in Pregnancy. Ir Med J 2024; 117:952. [PMID: 38683117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/01/2024]
|
2
|
Abstract
BACKGROUND Maternal obesity is a significant risk factor for unfavourable outcomes during pregnancy. However, the extent of this relationship is poorly defined in Irish mothers. AIMS This study was to compare maternal and perinatal outcomes between obese and non-obese mothers in an Irish population. METHODS A retrospective comparative study was conducted in a secondary level maternity unit for births recorded between January 2018 and January 2019 and 2,793 women were included. BMI calculated at booking visit was used to compare obese (BMI ≥ 30 kg/m2) and non-obese mothers (BMI < 30 kg/m2). RESULTS Of 2,793 women included in this study, 2111 had a BMI < 30 kg/m2 and 682 had a BMI ≥ 30 kg/m2. Obese women were less likely to experience spontaneous onset of labour (33.4% vs. 48.1%, p < 0.001) and more likely to be induced (37.2% vs. 31.0%, p = 0.002). Obesity was associated with a statistically significant increase in stillbirth, fetal macrosomia and emergency caesarean birth rates, whereas operative vaginal deliveries were significantly decreased. Miscarriage, shoulder dystocia, post-partum haemorrhage and spontaneous vaginal deliveries were reduced while elective caesarean birth and low birth weight incidence were increased in obese mothers; however, these results were not statistically significant. CONCLUSIONS This study highlights the magnitude of obstetric risks that are associated with maternal obesity within Irish population. Implementation of effective intervention strategies to reduce the number of obese women in pregnancy may have beneficial effects on pregnancy outcomes in Ireland.
Collapse
Affiliation(s)
- Orla Bracken
- School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland
| | - Ream Langhe
- School of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland.
| |
Collapse
|
3
|
Langhe R, Colussi M, Ciprike V, Akpan E. Brief communication: Impact of negative pressure dressing on surgical incisions following caesarean section. Eur J Obstet Gynecol Reprod Biol 2020; 253:343-344. [PMID: 32883532 DOI: 10.1016/j.ejogrb.2020.08.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2020] [Revised: 08/01/2020] [Accepted: 08/21/2020] [Indexed: 10/23/2022]
Affiliation(s)
- Ream Langhe
- Our Lady of Lourdes Hospital, Ireland; Royal College of Surgeons, Ireland.
| | | | | | - Etop Akpan
- Our Lady of Lourdes Hospital, Ireland; Royal College of Surgeons, Ireland
| |
Collapse
|
4
|
Javaid A, Langhe R, Munir A, Selvamani S. Spontaneous Uterine Inversion. Ir Med J 2020; 113:138. [PMID: 35603439] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Affiliation(s)
- A Javaid
- Department of Obstetrics & Gynaecology, Our Lady of Lourdes Hospital, Drogheda, Co Louth, Ireland
| | - R Langhe
- Department of Obstetrics & Gynaecology, Our Lady of Lourdes Hospital, Drogheda, Co Louth, Ireland
| | - A Munir
- Department of Obstetrics & Gynaecology, Our Lady of Lourdes Hospital, Drogheda, Co Louth, Ireland
| | - S Selvamani
- Department of Obstetrics & Gynaecology, Our Lady of Lourdes Hospital, Drogheda, Co Louth, Ireland
| |
Collapse
|
5
|
Langhe R, Akpan E, Selvamani S, McEntagart N. Umbilical Cord Stricture Causing Intrauterine Death. Ir Med J 2020; 113:62. [PMID: 32268055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Affiliation(s)
- R Langhe
- Department of Obstetrics and gynaecology, Our Lady of Lourdes hospital, Drogheda, Ireland
| | - E Akpan
- Department of Obstetrics and gynaecology, Our Lady of Lourdes hospital, Drogheda, Ireland
| | - S Selvamani
- Department of Obstetrics and gynaecology, Our Lady of Lourdes hospital, Drogheda, Ireland
| | - N McEntagart
- Department of Perinatal pathology, Rotunda hospital, Dublin, Ireland
| |
Collapse
|
6
|
Abstract
The classic features of molar pregnancy are irregular vaginal bleeding, hyperemesis, enlarged uterus for gestational age and early failed pregnancy. Less common presentations include hyperthyroidism, early onset pre-eclampsia or abdominal distension due to theca lutein cysts. Here, we present a case of molar pregnancy where a woman presented to the emergency department with symptoms of acute abdomen and was treated as ruptured ectopic pregnancy. The woman underwent laparoscopy and evacuation of retained products of conception. Histological examination of uterine curettage confirmed the diagnosis of a complete hydatidiform mole. The woman was discharged home in good general condition with a plan for serial beta-human chorionic gonadotropin (beta-hCG) follow-up. Complete follow-up includes use of contraception and follow-up after beta-hCG is negative for a year.
Collapse
Affiliation(s)
- Ream Langhe
- Department of Obstetrics and Gynaecology, Our Lady of Lourdes Hospital, Drogheda, Ireland
| | | | - Etop Akpan
- Department of Obstetrics and Gynaecology, Our Lady of Lourdes Hospital, Drogheda, Ireland
| | - Nor Azlia Abdul Wahab
- Department of Obstetrics and Gynaecology, Our Lady of Lourdes Hospital, Drogheda, Ireland
| |
Collapse
|
7
|
Langhe R, Blake M, Gannon M. Uterine Sacculation in Pregnancy. Ir Med J 2018; 111:683. [PMID: 29869863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Affiliation(s)
- R Langhe
- Department of Obstetrics & Gynaecology, Regional Hospital Mullingar, Longford Road, Co Westmeath
| | - M Blake
- Department of Obstetrics & Gynaecology, Regional Hospital Mullingar, Longford Road, Co Westmeath
| | - M Gannon
- Department of Obstetrics & Gynaecology, Regional Hospital Mullingar, Longford Road, Co Westmeath
| |
Collapse
|
8
|
Langhe R, Shah UF, Almshwt M. A Case of Postpartum HELLP Syndrome. Ir Med J 2017; 110:662. [PMID: 29465852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Affiliation(s)
- R Langhe
- Department of Obstetrics & Gynaecology, Regional Hospital Mullingar, LongFord Road, Co Westmeath
| | - U F Shah
- Department of Obstetrics & Gynaecology, Regional Hospital Mullingar, LongFord Road, Co Westmeath
| | - M Almshwt
- Department of Obstetrics & Gynaecology, Regional Hospital Mullingar, LongFord Road, Co Westmeath
| |
Collapse
|
9
|
Langhe R, Shah UF, Alfathil A, Gannon M. Silent uterine rupture in scarred uterus. BMJ Case Rep 2017; 2017:bcr-2016-218189. [PMID: 28343154 DOI: 10.1136/bcr-2016-218189] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Uterine rupture in pregnancy is a rare and catastrophic complication with a high incidence of fetal and maternal morbidity. Very few cases have been reported in the literature. CASE PRESENTATION A 28-year-old fifth gravid woman with a history of one caesarean section presented to our department at 39 weeks and 6 days gestation with complaints of headache, epigastric pain and nausea. Her blood pressure was elevated and there was proteinuria. Emergency caesarean section was performed in view of symptoms. Uterine rupture was found during the surgery. A live male infant was delivered in good condition. Postnatal recovery was unremarkable and the woman discharged on postoperative day 5. CONCLUSION Rupture of the uterus can present in third trimester even before labour with minimal or no symptoms.
Collapse
Affiliation(s)
- Ream Langhe
- Obstetrics and Gynaecology, Midland Regional Hospital Mullingar, Mullingar, Ireland
| | - Umme Farwa Shah
- Obstetrics and Gynaecology, Midland Regional Hospital Mullingar, Mullingar, Ireland
| | - Attia Alfathil
- Obstetrics and Gynaecology, Midland Regional Hospital Mullingar, Mullingar, Ireland
| | - Michael Gannon
- Obstetrics and Gynaecology, Midland Regional Hospital Mullingar, Mullingar, Ireland
| |
Collapse
|
10
|
Abu Saadeh F, Langhe R, Galvin DM, O Toole SA, O'Donnell DM, Gleeson N, Norris LA. Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy. Thromb Res 2016; 139:135-41. [PMID: 26916311 DOI: 10.1016/j.thromres.2016.01.027] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2015] [Revised: 12/18/2015] [Accepted: 01/31/2016] [Indexed: 12/19/2022]
Abstract
BACKGROUND Gynaecological cancers are associated with high rates of venous thromboembolism (VTE). Studies on ambulatory cancer patients do not support thromboprophylaxis during chemotherapy. Approximately 6-7% of gynaecological cancer patients suffer a postoperative VTE despite Low Molecular Weight Heparin prophylaxis (LMWH). Large cancer studies have shown that Calibrated Automated Thrombogram (CAT) and Microparticles (MP) assays may be useful in predicting VTE but data on gynaecological cancer patients is scarce. OBJECTIVE Our objective was to identify whether the CAT assay and MP functional assays have potential as biomarkers predictive of VTE in gynaecological cancer patients. PATIENTS AND METHODS Gynaecological cancer patients were investigated before surgery (n=146) and at 5, 14 and 42days post-surgery (n=78). Fourteen additional patients were investigated before chemotherapy and after 3 and 6 cycles of therapy. Thrombin generation was measured before and after addition of thrombomodulin. RESULTS Patients with clear cell cancer (CCC) of the ovary and patients with endometrial cancer had higher ETP and peak thrombin compared with patients with benign disease. Patients who developed VTE (n=8) following surgery had enhanced thrombin generation prior to surgery which persisted during the post-operative period despite LMWH prophylaxis. Both neoadjuvant and adjuvant chemotherapy showed increased thrombin generation following addition of thrombomodulin. There were no differences in MP levels during the study. CONCLUSIONS CAT assay shows potential as a promising biomarker for the prediction of VTE in gynaecological cancer patients. The identification of high risk patients combined with individualised LMWH prophylaxis might reduce VTE in this high risk group.
Collapse
Affiliation(s)
- F Abu Saadeh
- Department of Gynaecology Oncology, St James's Hospital, Dublin 8, Ireland.
| | - R Langhe
- Trinity College Department of Obstetrics and Gynaecology, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland
| | - D M Galvin
- Department of Gynaecology Oncology, St James's Hospital, Dublin 8, Ireland
| | - S A O Toole
- Trinity College Department of Obstetrics and Gynaecology, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland
| | - D M O'Donnell
- Department of Medical Oncology, St James's Hospital, Dublin 8, Ireland
| | - N Gleeson
- Department of Gynaecology Oncology, St James's Hospital, Dublin 8, Ireland; Trinity College Department of Obstetrics and Gynaecology, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland
| | - L A Norris
- Trinity College Department of Obstetrics and Gynaecology, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland
| |
Collapse
|
11
|
|
12
|
Langhe R, Norris L, Saadeh FA, Blackshields G, Varley R, Harrison A, Gleeson N, Spillane C, Martin C, O'Donnell DM, D'Arcy T, O'Leary J, O'Toole S. A novel serum microRNA panel to discriminate benign from malignant ovarian disease. Cancer Lett 2014; 356:628-36. [PMID: 25451316 DOI: 10.1016/j.canlet.2014.10.010] [Citation(s) in RCA: 66] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2014] [Revised: 10/08/2014] [Accepted: 10/08/2014] [Indexed: 12/19/2022]
Abstract
Ovarian cancer is the seventh most common cancer in women and the most frequent cause of gynaecological malignancy-related mortality in women. Currently, no standardized reliable screening test exists. MicroRNA profiling has allowed the identification of signatures associated with diagnosis, prognosis and response to treatment of human tumours. The aim of this study was to determine if a microRNA signature could distinguish between malignant and benign ovarian disease. A training set of 5 serous ovarian carcinomas and 5 benign serous cystadenomas were selected for the initial experiments. The validation set included 20 serous ovarian carcinomas and 20 benign serous cystadenomas. The serum/plasma focus microRNA Exiqon panel was used for the training set. For the validation set a pick and mix Exiqon panel, which focuses on microRNAs of interest was used. A panel of 4 microRNAs (let-7i-5p, miR-122, miR-152-5p and miR-25-3p) was significantly down regulated in cancer patients. These microRNAs target WNT signalling, AKT/mTOR and TLR-4/MyD88, which have previously been found to play a role in ovarian carcinogenesis and chemoresistance. let-7i-5p, miR-122, miR-152-5p and miR-25-3p could act as diagnostic biomarkers in ovarian cancer.
Collapse
Affiliation(s)
- Ream Langhe
- Department of Obstetrics and Gynaecology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland; Department of Histopathology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland.
| | - Lucy Norris
- Department of Obstetrics and Gynaecology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland
| | - Feras Abu Saadeh
- Department of Gynaecological-Oncology, St. James's Hospital, Dublin 8, Ireland
| | - Gordon Blackshields
- Department of Histopathology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland
| | - Rachel Varley
- Department of Obstetrics and Gynaecology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland
| | - Ashling Harrison
- Department of Obstetrics and Gynaecology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland
| | - Noreen Gleeson
- Department of Gynaecological-Oncology, St. James's Hospital, Dublin 8, Ireland
| | - Cathy Spillane
- Department of Histopathology, Trinity College Dublin, Coombe Women's and Infants University Hospital, Dublin 8, Ireland
| | - Cara Martin
- Department of Histopathology, Trinity College Dublin, Coombe Women's and Infants University Hospital, Dublin 8, Ireland
| | | | - Tom D'Arcy
- Department of Gynaecological-Oncology, St. James's Hospital, Dublin 8, Ireland
| | - John O'Leary
- Department of Histopathology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland; Department of Histopathology, Trinity College Dublin, Coombe Women's and Infants University Hospital, Dublin 8, Ireland
| | - Sharon O'Toole
- Department of Obstetrics and Gynaecology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland; Department of Histopathology, Trinity College Dublin, St. James's Hospital, Dublin 8, Ireland
| |
Collapse
|
13
|
Abu Saadeh F, Norris L, O'Toole S, Mohamed BM, Langhe R, O'Leary J, Gleeson N. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk. Thromb Res 2013; 132:627-34. [PMID: 24094893 DOI: 10.1016/j.thromres.2013.09.016] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2013] [Revised: 09/09/2013] [Accepted: 09/17/2013] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Ovarian cancer is known to display a particular association with venous thromboembolism (VTE) with reports up to 42% of patients developing thromboembolic complications. Tissue Factor (TF) and its inhibitor Tissue Factor Pathway Inhibitor (TFPI) have been implicated in VTE risk in cancer. The aim of this study was to measure tumour derived TF and TFPI and to investigate their potential role in VTE in ovarian cancer patients. METHODS TF and TFPI mRNA expression was measured using TaqMan real time PCR in 99 ovarian tumour samples. Nineteen cases complicated by VTE were matched to 19 cases without VTE. TF and TFPI protein levels were measured using ELISA and immunohistochemistry was used to localize TF expression. The role of TF expression on overall survival was also determined. RESULTS TF mRNA and protein expression was increased in tumours from patients with clear cell carcinoma (p<0.001). TF protein expression was also increased in endometroid carcinoma (P<0.01) compared with benign tumours. TFPI mRNA expression was increased in clear cell carcinoma (P<0.01). TF mRNA and antigen level was increased in malignant tumours of patients who developed VTE compared with matched malignant õtumours of patients who remained thrombosis free (P<0.01). There was no difference in TFPI expression between the two groups. CONCLUSION TF expression in ovarian cancer is significantly higher in patients who develop VTE. TF expression was increased in clear cell ovarian cancer and endometroid cancer and this may explain the higher risk of VTE in these subgroups. TF derived from these tumours may be the trigger for VTE in ovarian cancer.
Collapse
Affiliation(s)
- Feras Abu Saadeh
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James's Hospital, Dublin 8, Ireland.
| | | | | | | | | | | | | |
Collapse
|
14
|
Laios A, Mohamed BM, Kelly L, Flavin R, Finn S, McEvoy L, Gallagher M, Martin C, Sheils O, Ring M, Davies A, Lawson M, Gleeson N, D’Arcy T, d’Adhemar C, Norris L, Langhe R, Saadeh FA, O’Leary JJ, O’Toole SA. Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screening. Int J Mol Sci 2013; 14:2085-103. [PMID: 23340649 PMCID: PMC3565367 DOI: 10.3390/ijms14012085] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2012] [Revised: 01/05/2013] [Accepted: 01/06/2013] [Indexed: 02/08/2023] Open
Abstract
Platinum resistance is a major cause of treatment failure in ovarian cancer. We previously identified matrix metalloproteinase 9 (MMP-9) as a potential therapeutic target of chemoresistant disease. A2780cis (cisplatin-resistant) and A2780 (cisplatin-sensitive) ovarian carcinoma cell lines were used. The cytotoxic effect of MMP-9/MMP-2 inhibitor, (2R)-2-[(4-Biphenylsulfonyl) amino]-3 phenylpropionic acid (C21H19NO4S) alone or in combination with cisplatin was determined using high content screening. Protein expression was examined using immunohistochemistry and ELISA. Co-incubation of cisplatin and an MMP-9/MMP-2 inhibitor, (2R)-2-[(4-Biphenylsulfonyl) amino]-3 phenylpropionic acid (C21H19NO4S) resulted in significantly greater cytotoxicity as compared to either treatment alone in a cisplatin resistant MMP-9 overexpressing cell line; A2780cis. In addition, pre-incubating with MMP-9i prior to cisplatin further enhances the cytotoxic effect. No significant difference was observed in MMP-9 protein in tissue but a trend towards increased MMP-9 was observed in recurrent serum. We propose that MMP-9/MMP-2i may be utilized in the treatment of recurrent/chemoresistant ovarian cancers that overexpress MMP-9 mRNA but its role in vivo remains to be evaluated.
Collapse
Affiliation(s)
- Alexandros Laios
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (A.L.); (L.K.); (L.M.E.); (N.G.); (T.D.A.); (L.N.); (R.L.); (F.A.S.)
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Bashir M. Mohamed
- Department of Clinical Medicine, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (B.M.M.); (A.D.)
| | - Lynne Kelly
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (A.L.); (L.K.); (L.M.E.); (N.G.); (T.D.A.); (L.N.); (R.L.); (F.A.S.)
| | - Richard Flavin
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Stephen Finn
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Lynda McEvoy
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (A.L.); (L.K.); (L.M.E.); (N.G.); (T.D.A.); (L.N.); (R.L.); (F.A.S.)
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Michael Gallagher
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Cara Martin
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Orla Sheils
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Martina Ring
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Anthony Davies
- Department of Clinical Medicine, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (B.M.M.); (A.D.)
| | - Margaret Lawson
- Department of Histopathology, St. James’s Hospital, Dublin 8, Ireland; E-Mail:
| | - Noreen Gleeson
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (A.L.); (L.K.); (L.M.E.); (N.G.); (T.D.A.); (L.N.); (R.L.); (F.A.S.)
| | - Tom D’Arcy
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (A.L.); (L.K.); (L.M.E.); (N.G.); (T.D.A.); (L.N.); (R.L.); (F.A.S.)
| | - Charles d’Adhemar
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Lucy Norris
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (A.L.); (L.K.); (L.M.E.); (N.G.); (T.D.A.); (L.N.); (R.L.); (F.A.S.)
| | - Ream Langhe
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (A.L.); (L.K.); (L.M.E.); (N.G.); (T.D.A.); (L.N.); (R.L.); (F.A.S.)
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Feras Abu Saadeh
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (A.L.); (L.K.); (L.M.E.); (N.G.); (T.D.A.); (L.N.); (R.L.); (F.A.S.)
| | - John J. O’Leary
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| | - Sharon A. O’Toole
- Department of Obstetrics and Gynaecology, Trinity College Dublin, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland; E-Mails: (A.L.); (L.K.); (L.M.E.); (N.G.); (T.D.A.); (L.N.); (R.L.); (F.A.S.)
- Department of Histopathology, Trinity College Dublin, Sir Patrick Duns Research Laboratory, St. James’s Hospital and The Coombe Women and Infants University Hospital, Dublin 8, Ireland; E-Mails: (R.F.); (S.F.); (M.G.); (C.M.); (O.S.); (M.R.); (C.D.A.)
| |
Collapse
|
15
|
Saadeh FA, Norris L, O'Toole S, Langhe R, O'Leary J, Gleeson N. Does tissue factor and tissue factor pathway inhibitor over expression, play a role in the development of venous thromboembolism in ovarian cancer patients? Thromb Res 2012. [DOI: 10.1016/s0049-3848(12)70074-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
16
|
Saadeh FA, Norris L, O'Toole S, Langhe R, Gleeson N. Procoagulant activity in patients with gynaecological malignancies and the effect of neoadjuvant chemotherapy. Thromb Res 2012. [DOI: 10.1016/s0049-3848(12)70128-7] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|